Shoulder Innovations Q3 2026 net loss narrows 20% to $7 million
Bitget2026/11/05 22:23- Shoulder Innovations’ third-quarter 2026 net loss narrowed 20% year-over-year to $7 million; net revenue climbed 38% to $16.2 million.
- Research and development expenses more than doubled to $3.2 million, driven by new-product development, including substantial work on the InSet Neo robotic platform.
- The company completed initial surgeries with its InSet Go glenoid implant and launched its FDA-cleared N-22 humeral head.
- Full-year 2026 net revenue guidance rose to $68 million–$70 million from $67 million–$69 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Barrick’s Marquee gold project faces hazy study timing
Japanese and South Korean stock markets open
Marvell Technology (MRVL.US) $115 billion "merger of the century" faces lukewarm reception! Stock has dropped over 40%, experts estimate only a 50% chance of completion
Marvell plans to acquire Lamington for 115 billions USD to strengthen its position in AI, but the probability of completion is only 50%. The two stocks have dropped by nearly 40% and about 35% respectively, with Chinese regulatory approval being the biggest uncertainty.
Crypto prices
More
